Martin Freed

Martin I.
Freed was the founder of Civitas Therapeutics, Inc., founded in 2009, where the title held was Chief Medical Officer from 2010 to 2014.
Current jobs include Independent Director at Solid Biosciences, Inc. since 2018 and Director at Avilar Therapeutics, Inc. Former jobs include Director at InteKrin Therapeutics, Inc. from 2007 to 2010; Independent Director at Dicerna Pharmaceuticals, Inc. from 2016 to 2021; Independent Director at Sojournix, Inc. from 2017 to 2021; Senior Vice President-Clinical Development at Acorda Therapeutics, Inc. from 2014 to 2015; Chief Medical Officer at Taligen Therapeutics, Inc. from 2009 to 2010; Chief Medical Officer at Adnexus from 2007 to 2008; Chief Medical Officer at Vitae Pharmaceuticals LLC from 2005 to 2007; Chief Medical Officer at Avila Therapeutics, Inc. from 2009 to 2011; VP-Clinical Development & Medical Affairs at GlaxoSmithKline LLC; and VP-Clinical Development & Medical Affairs at Smithkline Beecham Pharmaceuticals (Canada) from 1991 to 2005.
Education includes undergraduate degree from the University of Delaware in 1986 and doctorate from Pennsylvania State University College of Medicine in 1986.